I reported previously (see here) on Israel’s Nucleix and its innovative blood and urine tests for early-stage cancer diagnostics. Nucleix has just received a grant of 2.5 million Euros from the EU’s Horizon 2020 research and innovation program – its second grant in two years.

https://www.calcalistech.com/ctech/articles/0,7340,L-3743363,00.html